INTERNATIONAL SOCIETY OF HYPERTENSION
The International Society of Hypertension (ISH) is the premier global body dedicated to research, education and clinical excellence in blood pressure and related cardiovascular disease. Highlighted activities include: Scientific Meetings, New Investigator and Women in Hypertension Research networks and educational activities with a focus on economically disadvantaged countries.
Financial health, per its FY2024 accounts
The accounts state that total income increased to £318,009 in 2024, but charitable expenditure of £334,904 exceeded this, resulting in a net reduction in funds. Per the trustees' report, unrestricted reserves stood at £851,458, which remains above the stated policy target of at least £500,000, though the charity notes uncertainty regarding long-term support from meetings and corporate members.
What the accounts disclose
“Journal of Hypertension Royalties 104,830” — page 22
“the Trustees have approved a strategy to maintain the balance of the accounts to a reasonable sum of at least ~£500,000 to guarantee sustainable charitable activities in the event of unfavourable financial circumstances.” — page 15
Register events
- Received assets from another charity (14/04/2025)
Trustees
- Dr Cesar Andres Romero
- Professor Bryan Williams
- Professor Debora Colombari
- Professor Erika Sherad Wilshire Jones
- Professor Georgios Stergiou
- Professor Hind Beheiry
- Professor Hiroshi Itoh
- Professor Jose Dagnovar Aristizabal-Ocampo
- Professor Kazuomi Kario
- Professor Myeong-Chan Cho
- Professor Tazeen Jafar
- Professor Ulrike Steckelings
- Professor Yan Li
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £318k | £335k |
Common questions
Is INTERNATIONAL SOCIETY OF HYPERTENSION financially healthy?
Per its FY2024 accounts: The accounts state that total income increased to £318,009 in 2024, but charitable expenditure of £334,904 exceeded this, resulting in a net reduction in funds. Per the trustees' report, unrestricted reserves stood at £851,458, which remains above the stated policy target of at least £500,000, though the charity notes uncertainty regarding long-term support from meetings and corporate members. Its FY2024 accounts were independently examined.